Researcher.Life Logo

Cancer Research and Treatment : Impact Factor & More

eISSN: 2005-9256pISSN: 1598-2998

Key Metrics

CiteScore
8.7
Eigenfactor
0.005 - 0.01
H-Index
52
Impact Factor
< 5
SJR
Q1Oncology
SNIP
1.72
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Research and Treatment

Cancer Research and Treatment Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher KOREAN CANCER ASSOCIATION
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2001
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Cancer Research and Treatment ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Research and Treatment

Association between FGFR2b Positivity and Survival Outcomes of Patients with Gastric Cancer Treated with First-Line Nivolumab Plus Chemotherapy.
  • 24 Nov 2025
  • Cancer research and treatment
Kidney Failure-Related Mortality in Patients with Cancer: Insights from the Cancer Public Library Database in South Korea.
  • 24 Nov 2025
  • Cancer research and treatment
The Application of Contrast-Enhanced Ultrasound Combined with Indocyanine Green Lymphography in the Management of Secondary Upper Limb Lymphedema.
  • 18 Nov 2025
  • Cancer research and treatment
Skeletal Muscle Index to Red Cell Distribution Width Ratio: A Novel Prognostic Indicator for Patients with Stage I-III Colorectal Cancer.
  • 17 Nov 2025
  • Cancer research and treatment
Dual-Functional PTX@Fe₃O₄ Nanobubbles: A Novel Theranostic Platform for Enhanced Ultrasound Imaging and Controlled Drug Delivery in Breast Cancer.
  • 17 Nov 2025
  • Cancer research and treatment
Chemotherapy-Free Salvage Therapy with Rituximab, Lenalidomide, and Poseltinib in Relapsed or Refractory Primary Central Nervous System Lymphoma: A Multi-Center, Phase II Study.
  • 12 Nov 2025
  • Cancer research and treatment
Association between FGFR2b Positivity and Survival Outcomes of Patients with Gastric Cancer Treated with First-Line Nivolumab Plus Chemotherapy.
  • 24 Nov 2025
  • Cancer research and treatment
Kidney Failure-Related Mortality in Patients with Cancer: Insights from the Cancer Public Library Database in South Korea.
  • 24 Nov 2025
  • Cancer research and treatment
The Application of Contrast-Enhanced Ultrasound Combined with Indocyanine Green Lymphography in the Management of Secondary Upper Limb Lymphedema.
  • 18 Nov 2025
  • Cancer research and treatment
Skeletal Muscle Index to Red Cell Distribution Width Ratio: A Novel Prognostic Indicator for Patients with Stage I-III Colorectal Cancer.
  • 17 Nov 2025
  • Cancer research and treatment
Dual-Functional PTX@Fe₃O₄ Nanobubbles: A Novel Theranostic Platform for Enhanced Ultrasound Imaging and Controlled Drug Delivery in Breast Cancer.
  • 17 Nov 2025
  • Cancer research and treatment
Chemotherapy-Free Salvage Therapy with Rituximab, Lenalidomide, and Poseltinib in Relapsed or Refractory Primary Central Nervous System Lymphoma: A Multi-Center, Phase II Study.
  • 12 Nov 2025
  • Cancer research and treatment

FAQs on Cancer Research and Treatment